{"id":"https://genegraph.clinicalgenome.org/r/b22e0383-b970-49e3-ab75-7c2ee9443473v1.1","type":"EvidenceStrengthAssertion","dc:description":"EIF2B2 was first associated with autosomal recessive leukoencephalopathy with vanishing white matter in 2001 (Leegwater., PMID: 11704758). Individuals with EIF2B2-related leukoencephalopathy present with gait dysfunction, spasticity, cognitive decline, and white matter abnormalities on MRI.  Some individuals develop ovarian failure. Onset is variable from infancy to adulthood, and progression of disease is often in the setting of fever, trauma, or stress. Vanishing white matter disease has also been referred to as Childhood Ataxia with Central Nervous System Hypomyelination (CACH). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found that a phenotypic spectrum exists and there is no difference in molecular mechanism or inheritance pattern. Therefore, we chose to curate this gene-disease relationship under the disease term leukoencephalopathy with vanishing white matter 2 (OMIM:606454, MONDO:0957870). \n\nTwelve variants (missense, nonsense, frameshift) that have been reported in 10 probands in 5 publications (PMIDs: 15136673, 29700822, 11704758, 25843247, 31438897) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is reported to be loss of function. This gene-disease relationship is also supported by experimental evidence, (PMIDs: 33300869, 24532666). The zebrafish model is associated with impaired motor behavior and abnormal CNS development. Protein interaction studies have shown that the subunit encoded by EIF2B2 interacts with the subunit of a previously curated gene EIF2B5.   In summary, definitive evidence supports the relationship between EIF2B2 and autosomal recessive leukoencephalopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Leukodystrophy and Leukoencephalopathy GCEP on the meeting date October 16, 2024 (SOP Version 11).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/b22e0383-b970-49e3-ab75-7c2ee9443473","GCISnapshot":"https://genegraph.clinicalgenome.org/r/875faedd-30bd-4e6d-803f-6244a04f37a5","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/875faedd-30bd-4e6d-803f-6244a04f37a5_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10107","date":"2024-12-11T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/875faedd-30bd-4e6d-803f-6244a04f37a5_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10107","date":"2024-12-12T00:41:48.784Z","role":"Publisher"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/875faedd-30bd-4e6d-803f-6244a04f37a5_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/875faedd-30bd-4e6d-803f-6244a04f37a5_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8a7b5a82-55e8-4bfd-bfb9-be0dbe67c78d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/68be391d-2000-49c1-9360-6817accc83b5","type":"Finding","dc:description":"eIF2B is a decameric, a dimer of eIF2B (beta, gamma, delta, epsilon) tetramers stabilized by 2 copies of eIF2B. EIF2B2 is experimentally proven to interact with EIF2B5, which has been established to cause EIF2B related disorder. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24532666","rdfs:label":"Protein Interaction","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/875faedd-30bd-4e6d-803f-6244a04f37a5_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1e75d5fe-a4d4-418d-91f6-d731aa196414","type":"EvidenceLine","dc:description":"Non-mammalian model","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/27668782-cd73-44db-b30e-ccbc5c121871","type":"Finding","dc:description":"Model recapitulates motor impairment and abnormal CNS development seen in patients with VWM. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33300869","rdfs:label":"Zebrafish","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/875faedd-30bd-4e6d-803f-6244a04f37a5_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e03c6d4-5f4e-4a40-bdd9-7db613ff1596_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e03c6d4-5f4e-4a40-bdd9-7db613ff1596","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11704758","rdfs:label":"Leegwater vwm63","allele":{"id":"https://genegraph.clinicalgenome.org/r/d0d41f63-b15b-446a-9f12-674d67c10cc1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014239.4(EIF2B2):c.638A>G (p.Glu213Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA116769"}},"phenotypeFreeText":"Individual part of originally published cohort with confirmed clinical data and/or imaging.","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/45b0dac7-1565-4eb9-abfe-4b5661a6701a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11704758","allele":{"id":"https://genegraph.clinicalgenome.org/r/d0d41f63-b15b-446a-9f12-674d67c10cc1"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/45b0dac7-1565-4eb9-abfe-4b5661a6701a","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/45b0dac7-1565-4eb9-abfe-4b5661a6701a_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/45b0dac7-1565-4eb9-abfe-4b5661a6701a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Cells from VWMD patient (study label: VWMD-2) hypersuppress translation during acute stress (Moon & Parker 2018)","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/bd2f823a-5f03-4622-bb94-852bd978ad40_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd2f823a-5f03-4622-bb94-852bd978ad40","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11704758","rdfs:label":"Leegwater vwm235","allele":[{"id":"https://genegraph.clinicalgenome.org/r/a7eaf701-2f54-4ef0-ad70-4da5c0c58323","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014239.4(EIF2B2):c.818A>G (p.Lys273Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7275055"}},{"id":"https://genegraph.clinicalgenome.org/r/d28a9c5b-72c9-4c11-9f38-5a060c780e0e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014239.4(EIF2B2):c.548del (p.Arg183GlnfsTer9)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7274971"}}],"firstTestingMethod":"PCR","phenotypeFreeText":"Individual part of originally published cohort with confirmed clinical data and/or imaging.","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/ede1a67e-4509-4228-a8ca-d8d3de838a64_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11704758","allele":{"id":"https://genegraph.clinicalgenome.org/r/d28a9c5b-72c9-4c11-9f38-5a060c780e0e"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/ade708ec-289f-4f6a-9e03-ecbb8584f486_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11704758","allele":{"id":"https://genegraph.clinicalgenome.org/r/a7eaf701-2f54-4ef0-ad70-4da5c0c58323"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/ede1a67e-4509-4228-a8ca-d8d3de838a64","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ede1a67e-4509-4228-a8ca-d8d3de838a64_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/ade708ec-289f-4f6a-9e03-ecbb8584f486","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ade708ec-289f-4f6a-9e03-ecbb8584f486_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/ade708ec-289f-4f6a-9e03-ecbb8584f486_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Cells from VWMD patient (study label: VWMD-2) hypersuppress translation during acute stress (Moon & Parker 2018)","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/4a9e678c-e482-44f4-94ef-3b9f214ba1ca_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4a9e678c-e482-44f4-94ef-3b9f214ba1ca","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15136673","rdfs:label":"Fogli 76-2","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":7,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/d0d41f63-b15b-446a-9f12-674d67c10cc1"},{"id":"https://genegraph.clinicalgenome.org/r/a7eaf701-2f54-4ef0-ad70-4da5c0c58323"}],"firstTestingMethod":"PCR","phenotypeFreeText":"motor signs potentially coupled with acute episode; cavitation present on brain MRI","phenotypes":"obo:HP_0002352","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/d6372995-f4be-467d-954e-06798bc0d782_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15136673","allele":{"id":"https://genegraph.clinicalgenome.org/r/a7eaf701-2f54-4ef0-ad70-4da5c0c58323"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/ac248e28-2013-4c0a-85fa-1da31b651a06_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15136673","allele":{"id":"https://genegraph.clinicalgenome.org/r/d0d41f63-b15b-446a-9f12-674d67c10cc1"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/ac248e28-2013-4c0a-85fa-1da31b651a06","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac248e28-2013-4c0a-85fa-1da31b651a06_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/ac248e28-2013-4c0a-85fa-1da31b651a06_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Percent GEF eIF2B activity decreased compared to controls (Fogli et al. 2004).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d6372995-f4be-467d-954e-06798bc0d782","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d6372995-f4be-467d-954e-06798bc0d782_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/d6372995-f4be-467d-954e-06798bc0d782_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Percent GEF eIF2B activity decreased compared to controls (Fogli et al. 2004).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/c416fb64-59c5-42c9-ad60-578ceccee1bd_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c416fb64-59c5-42c9-ad60-578ceccee1bd","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15136673","rdfs:label":"Fogli 992","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":8,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/72359676-6dfe-41a3-97e4-63c36c9b1d7a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014239.4(EIF2B2):c.547C>T (p.Arg183Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA116770"}},{"id":"https://genegraph.clinicalgenome.org/r/d0d41f63-b15b-446a-9f12-674d67c10cc1"}],"firstTestingMethod":"PCR","phenotypeFreeText":"school difficulties; motor signs; localized cavitation on brain MRI","phenotypes":["obo:HP_0002352","obo:HP_0001249"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/491a2685-e7c2-4f5b-b134-fcdc2f7c5e24_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15136673","allele":{"id":"https://genegraph.clinicalgenome.org/r/d0d41f63-b15b-446a-9f12-674d67c10cc1"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/2c487400-fe0e-49e9-89d0-966aa817d2a2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15136673","allele":{"id":"https://genegraph.clinicalgenome.org/r/72359676-6dfe-41a3-97e4-63c36c9b1d7a"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/2c487400-fe0e-49e9-89d0-966aa817d2a2","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2c487400-fe0e-49e9-89d0-966aa817d2a2_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/491a2685-e7c2-4f5b-b134-fcdc2f7c5e24","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/491a2685-e7c2-4f5b-b134-fcdc2f7c5e24_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/491a2685-e7c2-4f5b-b134-fcdc2f7c5e24_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Cells from VWMD patient (study label: VWMD-2) hypersuppress translation during acute stress (Moon & Parker 2018)","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/665d40d7-0f3f-4d26-bb6a-e3c70a82526d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/665d40d7-0f3f-4d26-bb6a-e3c70a82526d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15136673","rdfs:label":"Fogli 328","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":4,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/d0d41f63-b15b-446a-9f12-674d67c10cc1"},{"id":"https://genegraph.clinicalgenome.org/r/5c9bd9ab-58ec-4ef9-a480-53ce3c5d0deb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014239.4(EIF2B2):c.599G>C (p.Gly200Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA263654958"}}],"firstTestingMethod":"PCR","phenotypeFreeText":"delay in motor development in the first 2 years of age; speech delay; motor signs potentially coupled with acute episode; relapsing remitting disease; cavitation present on brain MRI","phenotypes":["obo:HP_0002352","obo:HP_0000750","obo:HP_0001270"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/162c1842-c3a7-4705-96eb-eeaad7b3bd00_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15136673","allele":{"id":"https://genegraph.clinicalgenome.org/r/d0d41f63-b15b-446a-9f12-674d67c10cc1"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/e85f7575-eff3-4554-b365-deffa616acf2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15136673","allele":{"id":"https://genegraph.clinicalgenome.org/r/5c9bd9ab-58ec-4ef9-a480-53ce3c5d0deb"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/e85f7575-eff3-4554-b365-deffa616acf2","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e85f7575-eff3-4554-b365-deffa616acf2_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/162c1842-c3a7-4705-96eb-eeaad7b3bd00","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/162c1842-c3a7-4705-96eb-eeaad7b3bd00_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/162c1842-c3a7-4705-96eb-eeaad7b3bd00_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Cells from VWMD patient (study label: VWMD-2) hypersuppress translation during acute stress (Moon & Parker 2018).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/ff7a9376-c259-4aa1-88bc-3602527e2a2d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ff7a9376-c259-4aa1-88bc-3602527e2a2d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25843247","rdfs:label":"Shimada Patient 3","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":8,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/10faed8a-629c-48dd-8e13-81c8ace0ad67","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014239.4(EIF2B2):c.254T>A (p.Val85Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA343824"}},{"id":"https://genegraph.clinicalgenome.org/r/42722500-d2f3-414a-b07a-5d3bdd9f293c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014239.4(EIF2B2):c.682A>G (p.Arg228Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7275018"}}],"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"spasticity; developmental delay; provoked by fever","phenotypes":["obo:HP_0012758","obo:HP_0002352","obo:HP_0001257"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/1e1dd7c9-3931-46c1-a0eb-813e4015a8d2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25843247","allele":{"id":"https://genegraph.clinicalgenome.org/r/42722500-d2f3-414a-b07a-5d3bdd9f293c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/b2057493-3056-4a08-948a-dbfe4167cd71_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25843247","allele":{"id":"https://genegraph.clinicalgenome.org/r/10faed8a-629c-48dd-8e13-81c8ace0ad67"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/b2057493-3056-4a08-948a-dbfe4167cd71","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b2057493-3056-4a08-948a-dbfe4167cd71_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/1e1dd7c9-3931-46c1-a0eb-813e4015a8d2","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1e1dd7c9-3931-46c1-a0eb-813e4015a8d2_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/a0f12570-7fba-47d3-9d2a-6172a3acde79_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a0f12570-7fba-47d3-9d2a-6172a3acde79","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11704758","rdfs:label":"Leegwater vwm83","allele":[{"id":"https://genegraph.clinicalgenome.org/r/d186d587-48ab-4a2d-9e99-36dd8adae475","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014239.4(EIF2B2):c.986G>T (p.Gly329Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA263656912"}},{"id":"https://genegraph.clinicalgenome.org/r/91528b19-79d8-464b-af99-97006585dac2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014239.4(EIF2B2):c.607_612delinsTG (p.Met203TrpfsTer2)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA116773"}}],"firstTestingMethod":"PCR","phenotypeFreeText":"Individual part of originally published cohort with confirmed clinical data and/or imaging.","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/c552700b-0057-48c1-8a3d-bbf931e641c1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11704758","allele":{"id":"https://genegraph.clinicalgenome.org/r/d186d587-48ab-4a2d-9e99-36dd8adae475"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/646c167f-8db9-4945-8f66-4c86633ce89d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11704758","allele":{"id":"https://genegraph.clinicalgenome.org/r/91528b19-79d8-464b-af99-97006585dac2"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/646c167f-8db9-4945-8f66-4c86633ce89d","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/646c167f-8db9-4945-8f66-4c86633ce89d_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/c552700b-0057-48c1-8a3d-bbf931e641c1","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c552700b-0057-48c1-8a3d-bbf931e641c1_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/c552700b-0057-48c1-8a3d-bbf931e641c1_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Percent GEF eIF2B activity decreased by <50% (Liu 2011).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/55c726af-0858-4108-8594-f66283da5617_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/55c726af-0858-4108-8594-f66283da5617","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29700822","rdfs:label":"Kuni 40","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":41,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/bb3994ae-2caf-4d54-abf9-5accd4383d10","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014239.4(EIF2B2):c.268C>T (p.Arg90Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA390424130"}},{"id":"https://genegraph.clinicalgenome.org/r/10faed8a-629c-48dd-8e13-81c8ace0ad67"}],"firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"leukoencephalopathy on MRI; headaches","phenotypes":["obo:HP_0002315","obo:HP_0002352","obo:HP_0007371","obo:HP_0002059","obo:HP_0032325"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/5b10460c-5546-497b-a960-b26a8e6a0c24_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29700822","allele":{"id":"https://genegraph.clinicalgenome.org/r/bb3994ae-2caf-4d54-abf9-5accd4383d10"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/61ef6651-3893-4a7e-9932-c17434ebd76e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29700822","allele":{"id":"https://genegraph.clinicalgenome.org/r/10faed8a-629c-48dd-8e13-81c8ace0ad67"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/61ef6651-3893-4a7e-9932-c17434ebd76e","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/61ef6651-3893-4a7e-9932-c17434ebd76e_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/5b10460c-5546-497b-a960-b26a8e6a0c24","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b10460c-5546-497b-a960-b26a8e6a0c24_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/aa393c8b-66d2-4a5f-8ff9-f049cd4dccba_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aa393c8b-66d2-4a5f-8ff9-f049cd4dccba","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31438897","rdfs:label":"Wei","ageType":"AgeAtReport","ageUnit":"Years","ageValue":25,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/10faed8a-629c-48dd-8e13-81c8ace0ad67"},{"id":"https://genegraph.clinicalgenome.org/r/a3685b71-95dd-4f39-afef-f4428105f4a6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014239.4(EIF2B2):c.496A>G (p.Met166Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA390425868"}}],"firstTestingMethod":"PCR","phenotypeFreeText":"menometrorrhagia; tremors; bilateral pyramidal tract injury; cerebellar ataxia; dementia; white matter abnormalities on brain MRI","phenotypes":["obo:HP_0400008","obo:HP_0002352","obo:HP_0001251"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/b68f5de7-e47a-4d89-8fb7-9d8735b5ae96_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31438897","allele":{"id":"https://genegraph.clinicalgenome.org/r/10faed8a-629c-48dd-8e13-81c8ace0ad67"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/5cb5a6e2-96ec-4ddb-82eb-f0b9e7005c8a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31438897","allele":{"id":"https://genegraph.clinicalgenome.org/r/a3685b71-95dd-4f39-afef-f4428105f4a6"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/5cb5a6e2-96ec-4ddb-82eb-f0b9e7005c8a","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5cb5a6e2-96ec-4ddb-82eb-f0b9e7005c8a_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/b68f5de7-e47a-4d89-8fb7-9d8735b5ae96","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b68f5de7-e47a-4d89-8fb7-9d8735b5ae96_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/57ed9e3d-a6a9-4570-bb68-067303b41d0f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/57ed9e3d-a6a9-4570-bb68-067303b41d0f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15136673","rdfs:label":"Fogli 433-2","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":18,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/7572c1dc-4235-43bf-9efc-e457392a9b7d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014239.4(EIF2B2):c.910G>T (p.Glu304Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA263656848"}},{"id":"https://genegraph.clinicalgenome.org/r/d0d41f63-b15b-446a-9f12-674d67c10cc1"}],"firstTestingMethod":"PCR","phenotypeFreeText":"Relapsing remitting disease; brain MRI demonstrates cavitation","phenotypes":"obo:HP_0002352","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/88a7262f-f3d1-41e9-871a-55e387150e99_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15136673","allele":{"id":"https://genegraph.clinicalgenome.org/r/d0d41f63-b15b-446a-9f12-674d67c10cc1"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/88d856db-bc6f-4793-9871-cd4f19dae597_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15136673","allele":{"id":"https://genegraph.clinicalgenome.org/r/7572c1dc-4235-43bf-9efc-e457392a9b7d"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/88a7262f-f3d1-41e9-871a-55e387150e99","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/88a7262f-f3d1-41e9-871a-55e387150e99_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/88a7262f-f3d1-41e9-871a-55e387150e99_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Cells from VWMD patient (study label: VWMD-2) hypersuppress translation during acute stress (Moon & Parker 2018)","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/88d856db-bc6f-4793-9871-cd4f19dae597","type":"EvidenceLine","dc:description":"Per ClinGen NDWG scoring guidelines proband scores are capped at 2","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/88d856db-bc6f-4793-9871-cd4f19dae597_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/88d856db-bc6f-4793-9871-cd4f19dae597_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Cells from VWMD patient (study label: VWMD-2) hypersuppress translation during acute stress (Moon & Parker 2018)","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":11.2}],"evidenceStrength":"Definitive","sequence":9505,"specifiedBy":"GeneValidityCriteria11","strengthScore":12.7,"subject":{"id":"https://genegraph.clinicalgenome.org/r/1eRGVWDGHEs","type":"GeneValidityProposition","disease":"obo:MONDO_0957870","gene":"hgnc:3258","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_875faedd-30bd-4e6d-803f-6244a04f37a5-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}